CDMRP Autism Career Development Award

The FY22 ARP Career Development Award supports early-career, independent investigators and/or the transition of established investigators from other research fields to conduct innovative, high-impact ideas or early-phase, proof-of-principle clinical trials with the potential to have a major impact on ASD and strongly encourages applications that address the critical needs of the ASD community in the following areas (listed alphabetically):

• Tests of implementation strategies to increase use of evidence-based practices

• Assessment of novel therapeutics using valid preclinical models

• Mechanisms of heterogeneous clinical expression of ASD

• Environmental risk factors

• Factors promoting success in key transitions to independence for individuals living with ASD

• Development of healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the life span and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief)

• Cultural, socioeconomic, and gender factors in diagnosis, treatment efficacy, delivery, and access to services

• Mechanisms underlying sex differences (i.e., prevalence, biological mechanisms, phenotypic expression, core and comorbid syndrome expression and outcomes, developmental trajectories, diagnosis, and treatment response)

• Mechanisms underlying conditions co-occurring with ASD (e.g., sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, and seizures)

• Factors impacting quality of life during geographic relocation, such as military permanent change of station

• Long-term treatment outcomes from previous clinical trials for ASD core symptoms or to alleviate co-occurring conditions

• Create tools and strategies to increase the speed with which evidence-based practices are deployed in community-based settings

• Improve diagnosis and access to services across the life span

• Interventions to support ASD adults, including transition to adulthood, mid-life, and late life needs

• Understanding heterogeneity in treatment response

It is expected that four awards will be granted. 

Funding: $550,000 total
Duration: 3 years

Research Authority due date: 16.5.22

Pre application (required) due date: 23.5.22
Full application due date: 18.8.22